Kansas City, Kan- Kristin Baker, an ultrasound tech, discovered her ovarian cancer during a training session. Despite vague symptoms like bloating and GI issues, her advanced-stage cancer was detected early.
Dr. Andrea Jewell, her oncologist, emphasized the lack of effective ovarian cancer screening methods and the importance of genetic testing.
Kristin Baker, Ovarian Cancer Patient
- Kristin describes the surreal experience of discovering the fluid on herself and seeking a second opinion from her colleagues.
- Kristin's treatment included chemotherapy and maintenance therapy with the PARP inhibitor Lynparza, which she completed after two years.
- She currently shows no evidence of the disease.
Dr. Jewell, Division Director Ovarian and Gynecologic Cancers, The University of Kansas Health System
- Dr. Jewell explains the role of PARP inhibitors in maintaining remission by inhibiting DNA repair in cancer cells.
- She highlights the importance of genetic testing for ovarian cancer patients and the potential for risk-reducing surgeries.
- Dr. Jewell explains the common spread of ovarian cancer within the abdomen and the role of the peritoneum.
Tuesday March 4th is the next Morning Medical Update- Triple Negative Breast Cancer Battle- A young mom discovers a lump and learns she has triple negative breast cancer. She shares her journey and the supports she found from family, friends and faith.
ATTENTION MEDIA: Please note access is with Microsoft Teams:
Join on your computer or mobile app
Click here to join the meeting
Meeting ID: 235 659 792 451
Passcode: 6CSfGE
Download Teams | Join on the web
Or call in (audio only)
+1 913-318-8863,566341546# United States, Kansas City
TVU Grid link: UoK_Health_SDI
Restream links: Facebook.com/kuhospital
YouTube.com/kuhospital
Send advance questions to medicalnewsnetwork@kumc.edu.